Resultats de la cerca - Michael Gregor
- Mostrar 1 - 20 resultats de 24
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
Quality of Life after Flap Reconstruction of the Distal Lower Extremity: Is There a Difference Between a Pedicled Suralis Flap and a Free Anterior Lateral Thigh Flap? per Schmidt, Karsten, Jakubietz, Michael Gregor, Gilbert, Fabian, Hausknecht, Franca, Meffert, Rainer Heribert, Jakubietz, Rafael Gregor
Publicat 2019Text -
6
HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL per Anita Pathil, Sorin Armeanu, Sascha Venturelli, Paolo Mascagni, Thomas S. Weiß, Michael Gregor, Ulrich M. Lauer, Michael Bitzer
Publicat 2006Artigo -
7
-
8
-
9
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib per Marius Horger, Ulrich M. Lauer, Christina Schraml, Christoph P. Berg, Ursula Koppenhöfer, Claus D. Claussen, Michael Gregor, Michael Bitzer
Publicat 2009Artigo -
10
Sendai Virus Infection Induces Apoptosis through Activation of Caspase-8 (FLICE) and Caspase-3 (CPP32) per Michael Bitzer, Florian Prinz, Manuel Bauer, Martin Spiegel, Wolfgang J. Neubert, Michael Gregor, Klaus Schulze‐Osthoff, Ulrich M. Lauer
Publicat 1999Artigo -
11
A functional CFTR protein is required for mouse intestinal cAMP‐, cGMP‐ and Ca<sup>2+</sup>‐dependent HCO<sub>3</sub><sup>−</sup> secretion per Ursula Seidler, Irina Blumenstein, Alexandra Kretz, D. Viellard‐Baron, Heidi Rossmann, William H Colledge, Martin Evans, R. Ratcliff, Michael Gregor
Publicat 1997Artigo -
12
Down-regulated in adenoma mediates apical Cl−/HCO3− exchange in rabbit, rat, and human duodenum per Petra Jacob, Heidi Rossmann, Georg Lamprecht, Alexandra Kretz, Christina Neff, Elena Lin–Wu, Michael Gregor, David A. Groneberg, Juha Kere, Ursula Seidler
Publicat 2002Artigo -
13
Epigenetic combination therapy as a tumor‐selective treatment approach for hepatocellular carcinoma per Sascha Venturelli, Sorin Armeanu, Anita Pathil, Chih‐Jen Hsieh, Thomas S. Weiß, Reinhard Vonthein, Manfred Wehrmann, Michael Gregor, Ulrich M. Lauer, Michael Bitzer
Publicat 2007Artigo -
14
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial per Oliver Nehls, Helmut Oettle, J. T. Hartmann, R. D. Hofheinz, H G Hass, Marius Horger, Ursula Koppenhöfer, Andreas Hochhaus, Jens Stieler, Jörg Trojan, Michael Gregor, Bodo Klump
Publicat 2008Artigo -
15
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up per Barbara Eichhorst, Tadeusz Robak, Emili Montserrat, Paolo Ghia, Carsten Utoft Niemann, Arnon P. Kater, Michael Gregor, Florence Cymbalista, Christian Buske, Peter Hillmen, Michael Hallek, Ulrich Mey
Publicat 2020Artigo -
16
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial per Verena Gotta, Nicolas Widmer, Laurent A. Décosterd, Yves Chalandon, Dominik Heim, Michael Gregor, Rudolf Benz, L. Leoncini-Franscini, Gabriela M. Baerlocher, Michel A. Duchosal, Chantal Csajka, Thierry Buclin
Publicat 2014Artigo -
17
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapo... per Oliver Nehls, T. Okech, C-J Hsieh, T Enzinger, Mario Sarbia, F Borchard, H. H. Gruenagel, V. Gaco, Holger G. Hass, Hendrik‐Tobias Arkenau, J. T. Hartmann, Rainer Porschen, Michael Gregor, Bodo Klump
Publicat 2007Artigo -
18
Ibrutinib Lead-in followed by Venetoclax Plus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia - SAKK 34/17 per Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, Katia Pini, Georg Stüssi, Gisela Müller, Nathan Cantoni, Richard Cathomas, Ulrich Mey, Anouk Widmer, Thorsten Zenz, Michael Gregor, Dominik Heim, Martin Andres, Rudolf Benz, Davide Rossi
Publicat 2025Artigo -
19
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis per Matthias Schwab, Elke Schaeffeler, Claudia Marx, Martin F. Fromm, Bernd Kaskas, Joerg Metzler, Eduard F. Stange, Hans Herfarth, Juergen Schöelmerich, Michael Gregor, S. Walker, Ingolf Cascorbi, Ivar Roots, Ulrich Brinkmann, Ulrich M. Zanger, Michel Eichelbaum
Publicat 2003Artigo -
20
Cytarabine Dose for Acute Myeloid Leukemia per Bob Löwenberg, Thomas Pabst, Edo Vellenga, Wim van Putten, Harry C. Schouten, Carlos Graux, Augustin Ferrant, Pieter Sonneveld, Bart J. Biemond, Aloïs Gratwohl, Georgine E. de Greef, Leo F. Verdonck, M Schaafsma, Michael Gregor, Matthias Theobald, Urs Schanz, Johan Maertens, Gert J. Ossenkoppele
Publicat 2011Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Biology
Biochemistry
Oncology
Chemistry
Gastroenterology
Leukemia
Gene
Apoptosis
Chemotherapy
Chronic lymphocytic leukemia
Disease
Genetics
Programmed cell death
Cancer
Clinical trial
Endocrinology
Immunology
Molecular biology
Venetoclax
Allele
Cancer research
Caspase
Caspase 3
Cell biology
Colorectal cancer
Combination therapy
Cytarabine
Enzyme